Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06727097 · ClinicalTrials.gov registry record

Post-Stroke Sensory Reweighting on Walking and Balance Outcomes

A clinical trial of Ischemic Stroke, sponsored by University of Cincinnati.

Recruiting
Registry status
45
Enrollment target
1
Study location

NCT06727097: Recruiting study of Ischemic Stroke, sponsored by University of Cincinnati.

NCT06727097 is a study of Ischemic Stroke that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 45 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06727097, a study of Ischemic Stroke, is actively recruiting participants, sponsored by University of Cincinnati.

RECRUITING
Registry status
45 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this proof-of-concept study is to longitudinally track the development of post-stroke sensory reweighting (PSR), identify associated structural neuroanatomical correlates, and investigate their relationship to walking and fall outcomes.

Primary Outcome

MCTSIB

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Posturography
  • DIAGNOSTIC_TEST Walking Speed
  • DIAGNOSTIC_TEST Instrumented 7M Timed UP and GO
  • OTHER Fall Event Records
  • DIAGNOSTIC_TEST MRI (3T)

Study Locations (1)

Ohio

  • University of Cincinnati College of Medicine - Cincinnati

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2024-11-01
Est. Completion 2026-08-30
University of Cincinnati

245 total trials

What NCT06727097 shows while recruiting

NCT06727097 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 5 interventions - of which Posturography is the first listed.

NCT06727097 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06727097 about?

NCT06727097 is a clinical study titled "Post-Stroke Sensory Reweighting on Walking and Balance Outcomes". The primary objective of this proof-of-concept study is to longitudinally track the development of post-stroke sensory reweighting (PSR), identify associated structural neuroanatomical correlates, and investigate their relationship to walking and fall outcomes.

What is the current status of trial NCT06727097?

This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2024-11-01. Estimated completion is 2026-08-30.

What conditions does trial NCT06727097 study?

This clinical trial studies the following conditions: Ischemic Stroke.

What interventions are being tested in trial NCT06727097?

The interventions under investigation include: Posturography (DIAGNOSTIC_TEST), Walking Speed (DIAGNOSTIC_TEST), Instrumented 7M Timed UP and GO (DIAGNOSTIC_TEST), Fall Event Records (OTHER), MRI (3T) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06727097?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06727097 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06727097's enrollment target sits among peer trials

45 47th of 66 higher than 20 of 66 other Ischemic Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06727097, the US trial registry maintained by the National Library of Medicine. NCT06727097 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.